If you purchased
Diffusion Pharmaceuticals Inc. securities and would like to join the action, please click "Join This Action" below.
We would handle the action on a contingent fee basis, whereby you would not be responsible for payment of our legal fees or expenses in the action.
DFFN STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE MERGER OF DIFFUSION PHARMACEUTICALS INC. IS FAIR TO SHAREHOLDERS
March 30, 2023.
New York, New York—Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) and EIP Pharma Inc. is fair to Diffusion shareholders.
The investigation concerns whether Diffusion and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Diffusion shareholders; and (2) disclose all material information necessary for Diffusion shareholders to adequately assess and value the merger consideration. On behalf of Diffusion shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.